So the price of Oxyado 7.5 (Pfizer reject product that we're now selling) is $6.43 per pill on GoodRx. Oxycodone Hcl generic is a buck and a quarter a pill. And Oxyado can still be crushed and snorted according to our own warnings! So no wonder it ain't selling at 4x the price. Hey management, wake up and smell the coffee. Idiots! We COULD sell this at a 10% premium. End of June sales will suck and we'll be blamed..... Layoffs imminent.
Good point. I don't see how from an economic POV we're going to survive. It makes no sense to keep a sales team or marketing unit at this time to sell these tired old licensed in products. 1Q revenue sucked and Q2 already looks bad given recent management communication/panic so a re-org is imminent in July. Brush up the resume.
LOL - downsizing - always June or December. The other thread about the $18.7 million loss lists all the probs with Sprix and Oxyado. TheStreet.com rates us at a D-.
